MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0000000000007606

Медицинская библиотека · Neurology · 2019

Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.

Coarelli Giulia, Schule Rebecca, van de Warrenburg Bart P C, De Jonghe Peter, Ewenczyk Claire, Martinuzzi Andrea, Synofzik Matthis, Hamer Elisa G, Baets Jonathan, Anheim Mathieu, Schöls Ludger, Deconinck Tine, Masrori Pegah, Fontaine Bertrand, Klockgether Thomas, D'Angelo Maria Grazia, Monin Marie-Lorraine, De Bleecker Jan, Migeotte Isabelle, Charles Perrine, Bassi Maria Teresa, Klopstock Thomas, Mochel Fanny, Ollagnon-Roman Elisabeth, D'Hooghe Marc, Kamm Christoph, Kurzwelly Delia, Papin Melanie, Davoine Claire-Sophie, Banneau Guillaume, Tezenas du Montcel Sophie, Seilhean Danielle, Brice Alexis, Duyckaerts Charles, Stevanin Giovanni, Durr Alexandra

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

We took advantage of a large multinational recruitment to delineate genotype-phenotype correlations in a large, trans-European multicenter cohort of patients with spastic paraplegia gene 7 (SPG7).

METHODS

We analyzed clinical and genetic data from 241 patients with SPG7, integrating neurologic follow-up data. One case was examined neuropathologically.

RESULTS

Patients with SPG7 had a mean age of 35.5 ± 14.3 years (n = 233) at onset and presented with spasticity (n = 89), ataxia (n = 74), or both (n = 45). At the first visit, patients with a longer disease duration (>20 years, n = 62) showed more cerebellar dysarthria (p < 0.05), deep sensory loss (p < 0.01), muscle wasting (p < 0.01), ophthalmoplegia (p < 0.05), and sphincter dysfunction (p < 0.05) than those with a shorter duration (<10 years, n = 93). Progression, measured by Scale for the Assessment and Rating of Ataxia evaluations, showed a mean annual increase of 1.0 ± 1.4 points in a subgroup of 30 patients. Patients homozygous for loss of function (LOF) variants (n = 65) presented significantly more often with pyramidal signs (p < 0.05), diminished visual acuity due to optic atrophy (p < 0.0001), and deep sensory loss (p < 0.0001) than those with at least 1 missense variant (n = 176). Patients with at least 1 Ala510Val variant (58%) were older (age 37.6 ± 13.7 vs 32.8 ± 14.6 years, p < 0.05) and showed ataxia at onset (p < 0.05). Neuropathologic examination revealed reduction of the pyramidal tract in the medulla oblongata and moderate loss of Purkinje cells and substantia nigra neurons.

CONCLUSIONS

This is the largest SPG7 cohort study to date and shows a spasticity-predominant phenotype of LOF variants and more frequent cerebellar ataxia and later onset in patients carrying at least 1 Ala510Val variant.

Для цитирования: Coarelli Giulia, Schule Rebecca, van de Warrenburg Bart P C, De Jonghe Peter, Ewenczyk Claire, Martinuzzi Andrea, Synofzik Matthis, Hamer Elisa G, Baets Jonathan, Anheim Mathieu, Schöls Ludger, Deconinck Tine, Masrori Pegah, Fontaine Bertrand, Klockgether Thomas, D'Angelo Maria Grazia, Monin Marie-Lorraine, De Bleecker Jan, Migeotte Isabelle, Charles Perrine, Bassi Maria Teresa, Klopstock Thomas, Mochel Fanny, Ollagnon-Roman Elisabeth, D'Hooghe Marc, Kamm Christoph, Kurzwelly Delia, Papin Melanie, Davoine Claire-Sophie, Banneau Guillaume, Tezenas du Montcel Sophie, Seilhean Danielle, Brice Alexis, Duyckaerts Charles, Stevanin Giovanni, Durr Alexandra. Loss of paraplegin drives spasticity rather than ataxia in a cohort of 241 patients with SPG7.. Neurology. 2019. DOI: 10.1212/wnl.0000000000007606.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.